Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7149-7155

  Sun, S Y ^a   Yue, P ^a   Hong, W K ^a   Lotan, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; DEATH RECEPTOR; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; RETINOID; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASES; CYTOCHROME C GROUP; DNA FRAGMENTATION; EPITHELIAL CELLS; GENES, P53; HUMANS; LUNG; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RETINOIDS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034671314     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Identification and characterization of a new member of the TNF family that induces apoptosis
2. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
3. Safety and antitumor activity of recombinant soluble Apo2 ligand
4. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
5. Death receptors: Signaling and modulation
6. The TRAIL to selective tumor death
7. On the TRAIL to a new cancer therapy
8. Apoptosis control by death and decoy receptors
9. APO2 ligand: A novel lethal weapon against malignant glioma?
10. p53-Dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha
11. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
12. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells
13. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
14. Identification and classification of p53-regulated genes
15. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor
16. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells
17. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest
18. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
19. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
20. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
21. p53 Independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
22. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro and causes growth inhibition in xenografts in vivo
23. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437)
24. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway
25. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells
26. Molecular determination of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
27. Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437
28. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells
29. p53 Gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
30. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells
31. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
32. Mitochondria and apoptosis
33. The Bcl-2 protein family: Arbiters of cell survival
34. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
35. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
36. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
37. Caspases. Enemies within
38. Caspases: The proteases of the apoptotic pathway
39. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
40. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
41. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade